Med News India #50 - Oxford Corona Vaccine Data in January || COVAXIN Phase 3 trial in 3 states

Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets TodayПодробнее

Covid-19 Vaccine: Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 DataПодробнее

Covid update: Covaxin’s phase 3 trials; free vaccine promise; SII’s partnershipПодробнее

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under ReviewПодробнее

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% EfficacyПодробнее

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | CovidПодробнее

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona VaccineПодробнее

Covid-19 News: 70-80% Decline In Participants For Phase3 Trial Of Bharat Biotech's CovaxinПодробнее

How effective is India's Covaxin again COVID and Delta | Here's what the numbers revealПодробнее

Covid-19 News: Coronavirus Vaccine Human Trial Begins, Result In 3 Months: AIIMS HeadПодробнее

Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel | The QuintПодробнее

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 TrialПодробнее

Bharat Biotech announces successful Phase-3 trial results of Covaxin | Made In India Vaccine | WIONПодробнее

Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy RateПодробнее

Covaxin 77.8% Effective In Phase 3 Trial Data: SourcesПодробнее

Bharat Biotech announces Covaxin's efficacy rate after final stage trials | COVID-19 Vaccine | NewsПодробнее

Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says ministerПодробнее

Oxford COVID-19 Vaccine Phase 3 Trials Begin In IndiaПодробнее

Covid-19 Live News: Bharat Biotech Submits Covaxin's Phase-3 Trial Data To DCGI | Breaking NewsПодробнее